Skip navigation

Global Disclosure Requirements | Patients as Partners | Data Sharing Policies | Publications Strategy

June 11-12, 2019
  • Amsterdam, The Netherlands

As regulatory authorities around the globe announce more guidance on clinical trial data disclosure, it is critically important for the biopharma and medical device industries to stay informed on regulatory changes and industry trends. CBI’s 8th Annual Publication and Clinical Trial Transparency Europe connects leading experts with the latest updates on global guidelines for clinical data sharing, best practices for collaborating with patients and benchmarking on innovative approaches to publishing. Take this opportunity to gather with colleagues from clinical trial transparency, data management, publications and medical writing to ensure that clinical trial data is reported accurately, redacted appropriately and your teams consider patient perspectives from study set up through post-market publications.

Gain Practical Insight on Critical Topics:

  • Explore Recent Trends and Innovations in Data Sharing
    and Transparency
  • Understand the Effects of the FDA Monetary Penalty Rule and HRA Requirements for Clinical Trial Transparency
  • Share Challenges and Lessons Learned in Global Clinical Trial Data Disclosure
  • Build a Positive Public Data Transparency Image for
    Your Organization
  • Align Timelines between Publications and Clinical Data Disclosure Teams for Streamlined Success

Featured Sessions:

  • Extended Workshop:
    Move Beyond the Quantification of Data Anonymisation
  • Patient Keynote:
    Patients as Collaborators — The DNA of the Clinical Trial Lifecycle

Choose Between Two Tailored Tracks:

I. Clinical Data Transparency

II. Publications

Previous Attendee Acclaim:

Informative and necessary congress.

Trial Transparency Manager, Sanofi

Well-organized conference allowing a lot of interactions
in between participants and between participants,
speakers, and sponsors.

Senior Medical Writer, Swedish Orphan Biovitrum

A good forum to share progress in the different
but interconnected fields!

Anonymous

Informative congress and necessary with an
ever-evolving regulatory landscape that impacts
publications and medical communication.

Medical Writer, Envision Pharma Group

Very comprehensive and followed a good flow.

Senior Medical Writer, Kinapse

Great Networking event, very open people.

Medical Writer, Boehringer Ingelheim Pharma GmbH